journal article·2022-02

Complex magnetic dynamics in an akaganéite-based iron deficiency drug

N. Novosel, N. Kalčec, I. Delač Marion, I. Šrut Rakić, Đ. Drobac, Ž. Marohnić, M. Prester

Publisher page

Abstract

Magnetic dynamics of iron oxyhydroxide akaganéite nanoparticles, functional building blocks of the newest generation iron deficiency drug Ferinject, has been studied. While magnetism of the involved nanoparticles relies in general on bulk properties of akaganéite, the low temperature magnetic dynamics of Ferinject differs a lot from large number of other iron-oxides-based intravenous drugs in pharmaceutical practice. Clear separation of the high-temperature (Curie) and the low-temperature (spin-freezing) regimes has been identified. Instead of standard single superparamagnetic blocking temperature we show that the spin freezing relies on the two dominant and superimposed relaxations, characterizing the temperature ranges 50–100 K and 4.2–10 K, respectively. Complex magnetic dynamics is interpreted to rely on presence of the two assemblies of nanoparticles differing significantly in their average sizes. Bimodal distribution of particle sizes has been confirmed using atomic force microscopy. The knowledge of the drug’s physicochemical characteristics has been thus significantly improved.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Characterization and Applications of Magnetic Nanoparticles · Iron oxide chemistry and applications · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (31)

Show source-provided references
1. Advances in magnetic nanoparticles for biomedical applications
2. Progress in applications of magnetic nanoparticles in biomedicine10.1088/0022-3727/42/22/224001 ↗
3. Magnetic nanoparticles
4. Quantitative spatial magnetization distribution in iron oxide nanocubes and nanospheres by polarized small-angle neutron scattering10.1088/1367-2630/14/1/013025 ↗
5. Evidence of random magnetic anisotropy in ferrihydrite nanoparticles based on analysis of statistical distributions10.1103/PhysRevB.77.134426 ↗
6. Intravenous irons: From basic science to clinical practice10.3390/ph11030082 ↗
7. Energy barrier distribution of a noninteracting nano-sized magnetic particle system10.1016/S0304-8853(96)00710-X ↗
8. Magnetic dynamics studies of the newest-generation iron deficiency drugs based on ferumoxytol and iron isomaltoside 100010.1063/1.4891297 ↗
9. Dipolar magnetism in ordered and disordered low-dimensional nanoparticle assemblies10.1038/srep01234 ↗
10. Arrangement at the nanoscale: Effect on magnetic particle hyperthermia10.1038/srep37934 ↗
11. Investigating the effect of magnetic dipole–dipole interaction on magnetic particle spectroscopy: implications for magnetic nanoparticle-based bioassays and magnetic particle imaging10.1088/1361-6463/ab2580 ↗
12. Orbital detection and implications of akaganéite on Mars10.1016/j.icarus.2015.01.020 ↗
13. Thermoinduced magnetic moment in akaganéite nanoparticles10.1103/PhysRevB.83.214426 ↗
14. Size distribution and frustrated antiferromagnetic coupling effects on the magnetic behavior of ultrafine Akaganéite β-FeOOH nanoparticles10.1021/jp5048634 ↗
15. Factors influencing safety and efficacy of intravenous iron-carbohydrate nanomedicines: From production to clinical practice
16. WSXM: A software for scanning probe microscopy and a tool for nanotechnology10.1063/1.2432410 ↗
17. Magnetostructural study of iron sucrose10.1016/j.jmmm.2005.01.045 ↗
18. Comparative study of iron-containing haematinics from the point of view of their magnetic properties10.1016/j.jmmm.2007.02.034 ↗
19. Blundell · 2001
20. Physicochemical characterization of iron carbohydrate colloid drug products10.1208/s12248-017-0126-0 ↗
21. Physico-chemical properties of the new generation IV iron preparations ferumoxytol, iron isomaltoside 1000 and ferric carboxymaltose10.1007/s10534-015-9845-9 ↗
22. A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implications10.1016/j.ejpb.2011.03.016 ↗
23. Why different iron(III)-oxyhydroxide complexes have different PK/PD characteristics and specific reactivities
24. Structural characterization of iron oxide/hydroxide nanoparticles in nine different parenteral drugs for the treatment of iron deficiency anaemia by electron diffraction (ED) and X-ray powder diffraction (XRPD)10.1016/j.jpba.2013.08.005 ↗
25. Iron nanomedicines induce Toll-like receptor activation, cytokine production and complement activation10.1016/j.biomaterials.2016.11.025 ↗
26. Ferromagnetic behavior and exchange bias effect in akaganeite nanorods10.1063/1.4918930 ↗
27. Morrish · 2001
28. Slow magnetic dynamics and hysteresis loops of the bulk ferromagnet Co7(TeO3)4Br610.1103/PhysRevB.84.064441 ↗
29. Engineered nanoparticles interacting with cells: Size matters10.1186/1477-3155-12-5 ↗
30. Quantum tunneling of magnetization in solids10.1142/S0217979292000670 ↗
31. Magnetic quantum tunneling in Ca3Co2O6 studied by ac susceptibility: Temperature and magnetic-field dependence of the spin-relaxation time10.1103/PhysRevB.70.214439 ↗